BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its board of directors. Jason Lewis has resigned as a director of the Company. We thank him for his three years of service as a director. Mr. Lewis will continue in his role as the Company’s Senior Vice President, Business Development. In conjunction with the resignation o
About Business Wire
